Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

---

Seyyar M., Kalem A., Sali M., Karabuğa B., Sahin T. K., Dişli A. K., ...Daha Fazla

Current oncology (Toronto, Ont.), cilt.33, sa.6, 2026 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 33 Sayı: 6
• Basım Tarihi: 2026
• Doi Numarası: 10.3390/curroncol33060365
• Dergi Adı: Current oncology (Toronto, Ont.)
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO)
• Recep Tayyip Erdoğan Üniversitesi Adresli: Evet